Fabry Nephropathy

What is Fabry nephropathy?

Fabry nephropathy is kidney damage caused by Fabry disease, a rare inherited condition in which the body cannot properly break down certain fatty substances. The word nephropathy simply means disease of the kidneys. In Fabry disease, a fatty substance called globotriaosylceramide (often shortened to Gb3 or GL-3) slowly builds up inside cells throughout the body, including the filtering units of the kidneys. Over many years this buildup can scar the kidney tissue, cause protein to leak into the urine, and gradually reduce the kidneys’ ability to clean the blood.

When people ask what is Fabry nephropathy, the short answer is that it is the kidney part of a whole-body condition. Fabry disease can also affect the heart, the nervous system, the skin, the eyes, and the digestive system. Kidney involvement is one of the most serious complications because, if it progresses, it can lead to kidney failure, meaning the kidneys can no longer do their job without dialysis or a transplant.

Fabry disease is passed down through families on the X chromosome. Because of this pattern, men and boys who inherit the altered gene usually develop the more severe, earlier form of the condition, often called classic Fabry disease. Women and girls who carry the altered gene were once thought to be unaffected, but it is now well recognized that many of them develop symptoms too, sometimes just as serious, although often later in life and with more variation from person to person. There is also a later-onset form in which the heart or kidneys may be affected without the classic childhood symptoms.

Fabry nephropathy is usually managed by a team that includes a nephrologist (a doctor who specializes in kidney disease), together with specialists in genetics, cardiology, and neurology. At Acibadem, kidney complications of inherited conditions such as Fabry disease are assessed and followed within the Nephrology Department.

Symptoms of Fabry nephropathy

Kidney damage from Fabry disease tends to be silent in its early stages. Many people have no kidney-related complaints at all until the disease is fairly advanced. This is why regular urine and blood testing is so important for anyone known to have Fabry disease. When Fabry nephropathy symptoms do appear, they are often the general signs of declining kidney function rather than anything unique to Fabry disease.

• Foamy or frothy urine, which can be a sign of protein leaking into the urine (proteinuria)
• Swelling of the ankles, feet, legs, or around the eyes (edema)
• Passing more urine at night or changes in how much urine is produced
• High blood pressure that is new or hard to control
• Tiredness, weakness, or difficulty concentrating
• Loss of appetite, nausea, or a metallic taste in the mouth in later stages
• Itchy skin or muscle cramps as waste products build up in the blood
• Shortness of breath from fluid buildup when kidney function is severely reduced

Because Fabry nephropathy is part of a wider condition, people often notice other Fabry-related symptoms long before kidney problems become obvious. In the classic form, these may begin in childhood or adolescence and include burning or shooting pain in the hands and feet (called acroparesthesia), episodes of severe pain triggered by heat, exercise, or fever, reduced ability to sweat, small dark red skin spots called angiokeratomas, ringing in the ears or hearing loss, and stomach pain or diarrhea. A characteristic cloudiness of the cornea, the clear front surface of the eye, may be seen during an eye examination and typically does not affect vision.

The pattern can differ by type and stage. In the classic form, protein in the urine may appear in the teenage years or early adulthood, and kidney function may begin to decline in the twenties or thirties if untreated. In the later-onset form, kidney or heart problems may be the first or only sign and may not appear until middle age. In women who carry the gene, symptoms vary widely; some have very mild or no kidney involvement, while others develop significant kidney disease.

Causes and risk factors

Understanding Fabry nephropathy causes starts with the genetics of Fabry disease. The condition is caused by changes (mutations) in a gene called GLA. This gene provides the instructions for making an enzyme called alpha-galactosidase A. Enzymes are proteins that speed up chemical reactions in the body. Alpha-galactosidase A normally works inside small recycling compartments of the cell called lysosomes, where it breaks down Gb3 and related fatty substances.

When the GLA gene is altered, the body produces too little of this enzyme, or an enzyme that does not work properly. Gb3 is then not broken down and instead accumulates inside cells. In the kidney, it builds up in several cell types, including the podocytes (specialized cells that form part of the blood filter), the cells lining the tiny blood vessels, and the cells of the kidney tubules. Over time this storage triggers inflammation and scarring, called fibrosis, and the kidney gradually loses working tissue. Some of the damage may become permanent even if the storage material is later reduced.

Fabry disease follows an X-linked inheritance pattern. Males have one X chromosome, so a single altered copy of the GLA gene causes the disease. Females have two X chromosomes, so they have one altered and one normal copy; the effect depends on which copy is active in different tissues, which helps explain why symptoms in women are so variable. A father with Fabry disease passes the altered gene to all of his daughters but none of his sons. A mother who carries the gene has a one-in-two chance of passing it to each child, whether a son or a daughter.

Risk factors for developing more severe or faster-progressing Fabry nephropathy are thought to include:

• Being male, especially with a gene change that leaves little or no working enzyme
• Having the classic form of Fabry disease rather than the later-onset form
• A family history of early kidney failure from Fabry disease
• Significant protein in the urine, which is associated with faster loss of kidney function
• High blood pressure that is not well controlled
• Late diagnosis or delayed start of disease-specific treatment
• Other kidney stressors such as diabetes, smoking, or certain medications that can harm the kidneys

Fabry disease is not caused by anything a person did or did not do, and it cannot be caught from another person.

Diagnosis

Fabry nephropathy diagnosis has two parts: confirming that a person has Fabry disease, and measuring how much the kidneys have been affected. Because the kidney symptoms are not specific, Fabry disease is sometimes first suspected when a person has unexplained protein in the urine or kidney failure at a young age, especially if there is a family history of kidney, heart, or stroke problems.

Tests used to confirm Fabry disease include:

• Enzyme activity test: a blood test that measures the activity of alpha-galactosidase A. In males, very low or absent activity strongly supports the diagnosis. In females, enzyme levels can be normal even when the disease is present, so this test alone is not enough to rule it out.
• Genetic testing: a blood or saliva test that looks for changes in the GLA gene. This is the definitive test and is essential for women. Identifying the exact gene change also helps guide treatment choices and allows relatives to be tested.
• Biomarker testing: measuring a related substance called lyso-Gb3 in blood or urine, which is often raised in Fabry disease and may help with diagnosis and monitoring.

Tests used to assess the kidneys include:

• Urine tests: checking for albumin or total protein in the urine, usually reported as a ratio to creatinine in a single sample. Protein in the urine is often the earliest measurable sign of Fabry nephropathy.
• Blood tests: measuring creatinine and sometimes cystatin C to calculate the estimated glomerular filtration rate (eGFR), a number that describes how well the kidneys are filtering.
• Kidney ultrasound: imaging to look at kidney size and structure and to exclude other causes of kidney disease. Small fluid-filled sacs called parapelvic cysts are sometimes seen in Fabry disease.
• Kidney biopsy: removing a tiny sample of kidney tissue with a needle for examination under a microscope. Under an electron microscope, the stored material forms distinctive layered deposits sometimes described as zebra bodies or myelin figures. A biopsy is not always needed once the diagnosis is confirmed genetically, but it may be recommended to judge how much damage has occurred, to rule out another kidney disease, or to help decide on treatment.

Once Fabry disease is confirmed in one person, doctors usually recommend that close relatives are offered genetic counseling and testing, because early diagnosis in family members may allow monitoring and treatment before serious damage develops.

Treatment options for Fabry nephropathy

There is currently no cure for Fabry disease, but there are treatments that may slow the buildup of storage material and protect the kidneys. Fabry nephropathy treatment options generally combine disease-specific therapy with the same supportive measures used for other forms of chronic kidney disease. The right combination depends on a person’s age, sex, gene change, symptoms, and how far the kidney disease has progressed.

Monitoring and observation. People with Fabry disease who have no kidney involvement yet, or only very mild changes, are usually followed with regular urine and blood tests, blood pressure checks, and assessments of the heart and nervous system. How often this happens depends on individual risk. Observation does not mean nothing is being done; it allows treatment to begin at the point when it is likely to help.

Enzyme replacement therapy (ERT). This involves giving a laboratory-made version of the missing alpha-galactosidase A enzyme by infusion into a vein, typically every two weeks, either in a clinic or, in some settings, at home. ERT can reduce the amount of Gb3 stored in kidney cells and, in many cases, may slow the decline in kidney function, particularly when started before there is heavy proteinuria or advanced scarring. It cannot reverse scarring that has already formed. Some people develop antibodies to the infused enzyme or have infusion-related reactions, which the treating team monitors and manages.

Oral chaperone therapy. For people whose specific GLA gene change produces an enzyme that is unstable rather than absent, a medicine taken by mouth called a pharmacological chaperone can help the person’s own enzyme fold correctly and reach the lysosome. It is only suitable for certain gene changes, which is one reason genetic testing is so important. Your doctor may discuss whether your gene change is considered responsive to this treatment.

Kidney-protective medicines. Regardless of disease-specific therapy, doctors often prescribe medicines from the groups known as ACE inhibitors or angiotensin receptor blockers (ARBs). These lower blood pressure and reduce pressure inside the kidney filters, which in turn reduces protein leakage. Controlling protein in the urine is considered one of the most important goals in Fabry nephropathy. Other blood pressure medicines may be added if needed.

General kidney care. This includes avoiding medicines that can harm the kidneys where possible, staying well hydrated, not smoking, managing cholesterol and blood sugar, and following dietary advice about salt and, in later stages, protein and potassium. A dietitian familiar with kidney disease may be involved.

Treatment for other Fabry symptoms. Nerve pain may be treated with specific pain medicines, and avoiding triggers such as overheating can help. Heart involvement is managed by a cardiologist. Hearing, digestive, and eye problems are addressed as needed. Treating the whole condition matters because heart and stroke complications are also major concerns in Fabry disease.

Dialysis and kidney transplant. If Fabry nephropathy progresses to kidney failure, dialysis can take over the filtering work of the kidneys. Kidney transplantation is often considered a good option for suitable candidates, because the transplanted kidney has normal enzyme activity and does not develop Fabry-related damage in the same way. Disease-specific therapy is usually continued after transplant to protect the heart and other organs. Transplant requires lifelong medicines to prevent rejection, and eligibility is assessed individually.

Rehabilitation and supportive care. Living with a chronic, inherited condition can be physically and emotionally demanding. Physical therapy for pain and mobility, psychological support, and genetic counseling for family planning decisions are often part of comprehensive care.

Living with Fabry nephropathy and outlook

The outlook for Fabry nephropathy varies widely. Historically, men with classic Fabry disease often reached kidney failure in early to middle adulthood, and kidney and heart complications shortened life expectancy. Since the introduction of enzyme replacement and chaperone therapies, together with earlier diagnosis and better blood pressure and proteinuria control, many people now live longer with more stable kidney function. However, treatment works best when started early, and it does not reverse established scarring, so outcomes are less favorable when the disease is found late.

Women with Fabry disease, and people with the later-onset form, generally have a slower course, but some still develop serious kidney or heart disease, so lifelong follow-up is recommended for everyone who carries the gene change.

Day to day, living well with Fabry nephropathy often involves keeping to scheduled infusions or medication, attending regular monitoring visits, taking blood pressure medicines consistently, and following kidney-friendly lifestyle advice. Many people find it helpful to keep a record of their test results so they can see trends over time. Because Fabry disease affects several organs, care is usually coordinated across specialties, and having one main point of contact within the medical team can make this easier.

Family considerations are an important part of living with an inherited condition. Genetic counseling can help people understand the chances of passing the gene to children, the options available, and how relatives might be tested. Patient organizations for rare and lysosomal storage diseases may also offer practical support and connection with others in a similar situation.

Frequently asked questions

What is Fabry nephropathy in simple terms?

Fabry nephropathy is kidney damage caused by Fabry disease, an inherited condition in which a missing or faulty enzyme allows a fatty substance to build up inside kidney cells. Over years this can cause protein to leak into the urine and gradually reduce kidney function. It is one of several organ complications of Fabry disease, alongside heart and nervous system involvement.

What are the first Fabry nephropathy symptoms?

The earliest sign is usually protein in the urine, which typically causes no symptoms and is found only on testing. Some people notice foamy urine or mild ankle swelling. Other Fabry symptoms such as burning pain in the hands and feet, reduced sweating, or skin spots often appear years before the kidneys are noticeably affected, especially in the classic form.

What causes Fabry nephropathy?

It is caused by changes in the GLA gene, which reduce the activity of the enzyme alpha-galactosidase A. Without enough working enzyme, a fatty substance called Gb3 accumulates in kidney cells, leading to inflammation and scarring. The gene change is inherited on the X chromosome and is not caused by lifestyle or infection.

How is Fabry nephropathy diagnosed?

Doctors confirm Fabry disease with an enzyme activity blood test and genetic testing of the GLA gene; genetic testing is essential in women because their enzyme levels can be normal. Kidney involvement is assessed with urine tests for protein, blood tests to estimate filtering function, ultrasound, and sometimes a kidney biopsy.

Can Fabry nephropathy be cured?

There is no cure at present. Enzyme replacement therapy and oral chaperone therapy may slow the disease and protect the kidneys, particularly when started early, and blood pressure medicines help reduce protein leakage. Scarring that has already developed cannot be reversed, so early diagnosis and treatment are important.

What are the Fabry nephropathy treatment options if the kidneys fail?

If kidney failure develops, dialysis can replace the filtering work of the kidneys, and kidney transplantation is often considered for suitable candidates. The transplanted kidney is not usually damaged by Fabry disease in the same way. Disease-specific therapy is generally continued after transplant to protect the heart and other organs.

Should my family members be tested?

In many cases, yes. Because Fabry disease is inherited, close relatives may carry the same gene change without knowing it. Genetic counseling can explain who is at risk and what testing involves. Identifying affected relatives early may allow monitoring and treatment before significant kidney or heart damage occurs.

When to see a doctor

Anyone with a known diagnosis of Fabry disease, or a family history of it, should have regular follow-up with a nephrologist and the wider care team, even if they feel well, because kidney damage is often silent in its early stages. You should also arrange a medical review if you notice persistent foamy urine, new swelling of the legs or around the eyes, rising blood pressure readings, unexplained tiredness, or a change in how much urine you pass.

Seek urgent medical attention if you experience any of the following red-flag warning signs:

• Sudden severe shortness of breath or difficulty breathing when lying flat
• Chest pain, pressure, or a fast, irregular, or very slow heartbeat
• Sudden weakness or numbness on one side of the body, facial drooping, trouble speaking, or sudden vision loss, which may indicate a stroke
• Passing very little or no urine for a day or more
• Confusion, extreme drowsiness, or seizures
• Rapid, marked swelling of the face, legs, or abdomen
• Severe or uncontrolled vomiting, especially if you also have kidney disease
• Fever, chills, or other signs of infection during dialysis or after a transplant
• A severe allergic-type reaction during or after an enzyme infusion, such as hives, swelling of the face or throat, or wheezing

These symptoms can signal a kidney, heart, or stroke emergency and should not be left to wait for a routine appointment.